Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review

Objective This study aimed to systematically review cost-effectiveness studies of newer antidiabetic medications. Methods The PubMed/MEDLINE, EMBASE, CINAHL Plus, Cochrane Library–NHS Economic Evaluation Database (Wiley), Cochrane Library–Health Technology Assessment Database (Wiley), Cochrane Libra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2019-06, Vol.37 (6), p.777-818
Hauptverfasser:	Hong, Dongzhe, Si, Lei, Jiang, Minghuan, Shao, Hui, Ming, Wai-kit, Zhao, Yingnan, Li, Yan, Shi, Lizheng
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Cost analysis Cost-Benefit Analysis Developing countries Diabetes Dipeptidyl-Peptidase IV Inhibitors - economics Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Disease Economics GLP-1 receptor agonists Glucagon Glucagon-Like Peptide-1 Receptor - agonists Glucose Health Administration Health care expenditures Health Economics Health technology assessment Humans Hypoglycemia Hypoglycemic Agents - economics Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Insulin resistance LDCs Libraries Medicine Medicine & Public Health Peptides Pharmacoeconomics and Health Outcomes Public Health Quality Quality of Life Research Reimbursement Sensitivity analysis Sodium Sodium-Glucose Transporter 2 Inhibitors - economics Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Systematic Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!